- Home
- SI vs JCE Comparison
SI vs JCE Comparison
Compare SI & JCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SI | JCE |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.1M | 247.6M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | SI | JCE |
|---|---|---|
| Price | $14.19 | $13.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $20.80 | N/A |
| AVG Volume (30 Days) | ★ 80.9K | 34.1K |
| Earning Date | 03-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $39.55 | N/A |
| Revenue Next Year | $31.24 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.92 | $12.51 |
| 52 Week High | $17.23 | $16.31 |
Technical Indicators
Market Signals| Indicator | SI | JCE |
|---|---|---|
| Relative Strength Index (RSI) | 48.72 | 21.39 |
| Support Level | $13.43 | N/A |
| Resistance Level | $15.85 | $15.88 |
| Average True Range (ATR) | 0.82 | 0.30 |
| MACD | -0.08 | -0.09 |
| Stochastic Oscillator | 36.43 | 1.23 |
Price Performance
Historical ComparisonAbout SI Shoulder Innovations Inc.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest
Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the S&P 500 Index. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities.